0001415889-22-006520.txt : 20220613 0001415889-22-006520.hdr.sgml : 20220613 20220613190932 ACCESSION NUMBER: 0001415889-22-006520 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220610 FILED AS OF DATE: 20220613 DATE AS OF CHANGE: 20220613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mayweg Alexander CENTRAL INDEX KEY: 0001786260 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39200 FILM NUMBER: 221013045 MAIL ADDRESS: STREET 1: C/O VERSANT VENTURES, AESCHENVORSTADT 36 CITY: BASEL STATE: V8 ZIP: 4051 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Black Diamond Therapeutics, Inc. CENTRAL INDEX KEY: 0001701541 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MAIN STREET, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-417-5868 MAIL ADDRESS: STREET 1: ONE MAIN STREET, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Aset Therapeutics, Inc. DATE OF NAME CHANGE: 20170321 4 1 form4-06132022_040616.xml X0306 4 2022-06-10 0001701541 Black Diamond Therapeutics, Inc. BDTX 0001786260 Mayweg Alexander C/O BLACK DIAMOND THERAPEUTICS, INC. ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 true false false false Stock Option (Right to Buy) 2.14 2022-06-10 4 A 0 15000 0 A 2032-06-09 Common Stock 15000 15000 D The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 7, 2023 or (ii) the Issuer's next annual meeting of stockholders. /s/ Karin Yoo, Attorney-in-Fact 2022-06-13